CIBC Private Wealth Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.09K | Sell |
|
|||||
|
2025
Q1 | $19.6K | Buy |
|
|||||
|
2024
Q4 | $17.7K | Hold |
|
|||||
|
2024
Q3 | $16K | Hold |
|
|||||
|
2024
Q2 | $13.9K | Hold |
|
|||||
|
2024
Q1 | $11.8K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $1.04M | Hold |
|
|||||
|
2022
Q2 | $1.07M | Hold |
|
|||||
|
2022
Q1 | $1.35M | Sell |
|
|||||
|
2021
Q4 | $1.86M | Sell |
|
|||||
|
2021
Q3 | $1.7M | Sell |
|
|||||
|
2021
Q2 | $1.85M | Sell |
|
|||||
|
2021
Q1 | $2.15M | Buy |
|
|||||
|
2020
Q4 | $1.31M | Sell |
|
|||||
|
2020
Q3 | $1.43M | Buy |
|
|||||
|
2020
Q2 | $1.67M | Sell |
|
|||||
|
2020
Q1 | $1.42M | Sell |
|
|||||
|
2019
Q4 | $2.33M | Sell |
|
|||||
|
2019
Q3 | $6.88M | Sell |
|
|||||
|
2019
Q2 | $8.29M | Sell |
|
|||||
|
2019
Q1 | $9.65M | Buy |
|
|||||
|
2018
Q4 | $9.38M | Buy |
|
|||||
|
2018
Q3 | $16.5M | Sell |
|
|||||
|
2018
Q2 | $14.5M | Sell |
|
|||||
|
2018
Q1 | $24.4M | Buy |
|
|||||
|
2017
Q4 | $20.1M | Buy |
|
|||||
|
2017
Q3 | $19.6M | Buy |
|
|||||
|
2017
Q2 | $17.2M | Sell |
|
|||||
|
2017
Q1 | $15.1M | Sell |
|
|||||
|
2016
Q4 | $14.6M | Buy |
|
|||||
|
2016
Q3 | $14.6M | Sell |
|
|||||
|
2016
Q2 | $20M | Buy |
|